一、个人简介
罗开沛，副教授，硕士生导师，党委研究生工作部副部长、研究生院副院长（挂职）。博士毕业于中国药科大学药学院药剂学专业。入选中华中医药学会青年人才托举工程，成都中医药大学杏林学者“1313”高层次人才。担任国家自然科学基金委、教育部学位论文、四川省科技计划项目、宁夏回族自治区科技项目等评审专家，并兼任中华中医药学会中成药分会青年委员。
主要从事中药新型给药系统研究。主持国家自然科学基金青年项目、中国博士后科学基金面上项目、四川省自然科学基金面上项目等科研项目。在Biomaterials、Journal of Controlled Release、Small、Chemical Engineering Journal、Acta Biomaterialia等国内外期刊发表学术论文50余篇。为Journal of Controlled Release、Acta Pharmaceutica Sinica B、Journal of Nanobiotechnology、Carbohydrate Polymers等期刊特邀审稿人。任Chinese Medicine、Science of Traditional Chinese Medicine、Nano TransMed、《沈阳药科大学学报》、《成都中医药大学学报》、《药学研究》等杂志青年编委。指导研究生获得国家奖学金、省级/校级优秀毕业生等荣誉。以第一指导教师指导本科生荣获“全国大学生药苑论坛”创新成果一等奖及优秀论文奖，指导大学生创新创业课题立项3项，获评优秀学士学位论文指导教师。
联系方式：luokaipei@cdutcm.edu.cn
二、代表性科研项目
1.国家自然科学基金青年项目，82204633，2023.01-2025.12，主持
2.中国博士后科学基金面上项目，2021M700550，2021.12-2024.08，主持
3.四川省自然科学基金面上项目，2024NSFSC2112，2024.11-2026.10，主持
4.四川省自然科学基金面上项目，2022NSFSC0634，2022.01-2023.12，主持
5.中华中医药学会（2024-2026年度）青年人才托举工程，2024-QNRC2-B28，主持
三、代表性学术论文
1.Yingjie Jiang, Zonglan Hu, Yuyu Wei, Yufei Su, Yanrui Yang, Aikepaer Aikedai, Weiwei Liao, Yuting Wei, Xinyu Zeng, Kun Qian, Qihang Ding*, Lu Yang*, Zhen Cheng*, Kaipei Luo*. Biomimetic cell membrane-mediated nanodelivery platform based on natural products: Emerging strategies for cancer combination therapy. Biomaterials, 2026, 328: 123908.（IF: 12.9）
2.Yuxin Wu, Yufei Su, Yuting Wei, Meiqing Shui, Wanrong Li, Lu Yang*, Kaipei Luo*. Nanomedicine for colorectal cancer therapy by remodeling the immune microenvironment. Journal of Controlled Release, 2026, 394: 114915.（IF: 11.5）
3.Kaipei Luo*, Qiuxia Li, Siyin Chen, Qingya Jia, Yuxin Wu, Weiwei Liao, Yufei Su, Liping Chen, Xiao Wang, Zhimin Chen, Xiaofang Li, Ling Li, Lu Yang*. Pullulan-stabilized gliadin nanocomplexes loaded with astragaloside IV: Fabrication, characterization and treatment of ulcerative colitis. Carbohydrate Polymers, 2026, 378: 124899. (IF: 12.5)
4.Chunmei Yan, Yuxin Zhao, Xiaolian Liu, Yingjie Jiang, Qiuxia Li, Lu Yang*, Xiaofang Li*, Kaipei Luo*. Self-delivery Nano-booster to Enhance Immunogenic Cell Death for Cancer Chemoimmunotherapy. ACS Applied Materials & Interfaces, 2024, 16: 33169-33181.（IF: 9.5）
5.Kaipei Luo*, Lu Yang, Chunmei Yan, Yuxin Zhao, Qiuxia Li, Xing Liu, Long Xie, Qiang Sun, Xiaofang Li*. A dual-targeting liposome enhances triple-negative breast cancer chemoimmunotherapy through inducing immunogenic cell death and inhibiting STAT3 activation. Small, 2023, 19: 2302834.（IF: 13.3，封面论文）
6.Qiuxia Li, Xing Liu, Chunmei Yan, Bolin Zhao, Yuxin Zhao, Lu Yang, Mingyi Shi, Hua Yu*, Xiaofang Li*, Kaipei Luo*. Polysaccharide-based stimulus-responsive nanomedicines for combination cancer immunotherapy. Small, 2023, 19: 2206211.（IF: 13.3）
7.Chunmei Yan, Qiuxia Li, Qiang Sun, Lu Yang, Xing Liu, Yuxin Zhao, Mingyi Shi, Xiaofang Li*, Kaipei Luo*. Promising nanomedicines of shikonin for cancer therapy. International Journal of Nanomedicine, 2023, 18: 1195-1218.（IF: 8.0，ESI高被引论文）
8.Kaipei Luo, Yunfei Lian, Min Zhang, Hua Yu, Guangji Wang, Juan Li*. Charge convertible biomimetic micellar nanoparticles for enhanced melanoma-targeted therapy through tumor cells and tumor-associated macrophages dual chemotherapy with IDO immunotherapy. Chemical Engineering Journal, 2021, 412: 128659.（IF: 16.744）
9.Kaipei Luo, Yi Gao, Shaoping Yin, Yawen Yao, Hua Yu*, Guangji Wang, Juan Li*. Co-delivery of paclitaxel and STAT3 siRNA by multifunctional nanocomplexes for targeted treatment of metastatic breast cancer. Acta Biomaterialia, 2021, 134: 650-664.（IF: 10.633）
10.Kaipei Luo, Feng Xu, Tianyi Yao, Jianping Zhu, Hua Yu, Guangji Wang, Juan Li*. TPGS and chondroitin sulfate dual-modified lipid-albumin nanosystem enhances the targeted therapy of chemotherapeutic agent against multidrug-resistant cancer. International Journal of Biological Macromolecules, 2021, 183: 1270-1282.（IF: 8.025）
